Nexnos Pharma Limited - Company Profile

It is a healthcare public limited company based in Chittorgarh, Rajasthan, India, established in 2007.
2007 Chittorgarh, Rajasthan, India Active
Last Updated:
Access Report
About Nexnos Pharma Limited

Nexnos Pharma Limited, a active public limited company, was established on 14 August 2007 in Chittorgarh, Rajasthan, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24100RJ2007PLC024845. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.91 Cr.

Formerly known as Asnani Brokers Private Limited, Nexnos Pharma Limited. It upholds a compliant status. Its leadership includes Kamal Asnani (Director), Vinod Asnani (Director), Rajesh Peswani (Director). Past directors included Rameshchandra. It holds ₹12.00 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 103, Pratap Nagar, Sindhi Colony, Chittorgarh, Rajasthan, 312001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100RJ2007PLC024845

  • Registration Number

    024845

  • Incorporation Date

    14 August 2007

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹1.91 Cr

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 1.91 Cr
  • Company Age 18 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 12.00 Cr
  • Satisfied Charges ₹ 12.00 Cr
Company report

Nexnos Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nexnos Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nexnos Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Kamal Asnani Director 14 Aug 2007 Current
Vinod Asnani Director 14 Aug 2007 Current
Rajesh Peswani Director 20 Mar 2024 Current
Rameshchandra Director 03 May 2023 Current
Ashish Kumar Agrawal Director 03 May 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Mar 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nexnos Pharma.
Nexnos Pharma revenue growth over time
Nexnos Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nexnos Pharma?

Unlock access to Nexnos Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹120,000,000.00

Satisfied Charges

₹120,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 12.00 Cr
Latest Charge Details
Date Lender Amount Status
19 Jun 2024 Others ₹12.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nexnos Pharma?

Unlock and access historical data on people associated with Nexnos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nexnos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexnos Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nexnos Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 19 Jun 2024 via Charge ID 100936082 with Others was fully satisfied on 02 Dec 2025. was documented.

  • Annual General Meeting

    The activity Nexnos Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nexnos Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was completed.

  • Charges

    Progress on A charge with Others of Rs. 12.00 Cr registered on 19 Jun 2024 with Charge ID 100936082 was modified on 07 Nov 2024. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100936082 was registered on 19 Jun 2024. was completed.

  • Director Appointment

    Progress on Rajesh Peswani was appointed as a Director was appointed as a Director on 20 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nexnos Pharma Limited?

The CIN of Nexnos Pharma Limited is U24100RJ2007PLC024845.

Where is Nexnos Pharma Limited headquartered?

Nexnos Pharma Limited is headquartered at 103, Pratap Nagar, Sindhi Colony, Chittorgarh, Rajasthan, 312001.

When was Nexnos Pharma Limited incorporated?

Nexnos Pharma Limited was incorporated on 14 August 2007.

Who are the current directors of Nexnos Pharma Limited?

The current directors of Nexnos Pharma Limited are

What is the primary industry of Nexnos Pharma Limited?

The primary industry of Nexnos Pharma Limited is Trade.

Is Nexnos Pharma Limited a listed company?

Nexnos Pharma Limited is unlisted.

What is the capital structure of Nexnos Pharma Limited?

The authorized capital of Nexnos Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹1.91 Cr.

What is the compliance status of Nexnos Pharma Limited?

The compliance status of Nexnos Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available